# Treatment of Adolescent Suicide Attempters (TASA)

> **NCT00080158** · PHASE2,PHASE3 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 120 (—)

## Conditions studied

- Depression
- Suicide, Attempted

## Interventions

- **DRUG:** fluoxetine
- **DRUG:** sertraline
- **DRUG:** citalopram
- **DRUG:** escitalopram
- **DRUG:** bupropion
- **DRUG:** mirtazapine
- **DRUG:** venlafaxine
- **DRUG:** lithium
- **BEHAVIORAL:** Cognitive Behavioral Therapy

## Key facts

- **NCT ID:** NCT00080158
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 120 (—)
- **Last updated:** 2020-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00080158

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00080158, "Treatment of Adolescent Suicide Attempters (TASA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00080158. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*